Galderma Drops MetroGel Patent Suit V. Tolmar

Law360, New York (April 24, 2009, 12:00 AM EDT) -- Swiss dermatological drugmaker Galderma SA has dropped its patent infringement suit against rival pharmaceutical company Tolmar Inc. over rosacea treatment MetroGel.

A judge for the U.S. District Court for the District of Colorado approved Galderma’s voluntary dismissal on Thursday, tossing the complaint less than two months after it was filed.

A representative for Galderman could not immediately be reached to elaborate on the reason for the dismissal.

Galderma hit Colorado-based Tolmar with the lawsuit on March 4 after Tolmar submitted an abbreviated new drug application to...
To view the full article, register now.